535 reports of this reaction
2.4% of all TRETINOIN reports
#3 most reported adverse reaction
PAIN is the #3 most commonly reported adverse reaction for TRETINOIN, manufactured by Bausch Health US, LLC. There are 535 FDA adverse event reports linking TRETINOIN to PAIN. This represents approximately 2.4% of all 22,211 adverse event reports for this drug.
Patients taking TRETINOIN who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for TRETINOIN, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for TRETINOIN:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 535 FDA reports for TRETINOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.4% of all adverse event reports for TRETINOIN, making it one of the most commonly reported side effect.
If you experience pain while taking TRETINOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.